Loading organizations...
Loading organizations...
Develops antibacterial products to combat antimicrobial resistance.
Trobix Bio has raised $6.0M across 2 funding rounds.
Trobix Bio has raised $6.0M in total across 2 funding rounds.
Trobix Bio has raised $6.0M in total across 2 funding rounds.
Trobix Bio's investors include Eyal Agmoni, Chartered Opus.
Trobix Bio has raised $6.0M across 2 funding rounds. Most recently, it raised $3.0M Series A Extension in March 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 30, 2023 | $3.0M Series A Extension | Eyal Agmoni | |
| Jul 31, 2020 | $3.0M Series A | Chartered Opus |